INmune Bio Inc. (INMB)

AI Score

Unlock

7.94

-0.10 (-1.24%)

At close: Apr 24, 2025, 3:59 PM

INmune Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016
Net Income	-42.08M	-41.27M	-37.74M	-34.5M	-30.01M	-27.43M	-26.59M	-26.93M	-27.3M	-31.14M	-32.87M	-32.69M	-30.34M	-23.87M	-19.13M	-14.58M	-12.1M	-11.21M	-9.56M	-7.85M	-7.68M	-7.24M	-5.71M	-11.49M	-12.44M	-10.99M	-9.76M	-3.75M	-870.34K	-576.78K	-323.45K	-158.32K	-188.87K	-54.2K
Depreciation & Amortization	n/a	n/a	24K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	7.61M	7.73M	7.9M	7.41M	7.37M	7.28M	7.33M	7.35M	7.15M	6.88M	6.55M	5.43M	4.8M	3.98M	3.42M	3.33M	3.11M	3.58M	3.51M	3.8M	4.1M	3.88M	3.88M	8.51M	10M	9.21M	8.23M	2.66M	199.56K	36.92K	36.92K	n/a	n/a	n/a
Other Working Capital	-3.22M	-10.85M	-5.41M	-4.45M	1.7M	5.35M	4.85M	4.75M	-4.27M	-2.08M	-4.56M	-6.18M	-5.35M	-4.32M	-2.71M	-2.53M	-1.03M	-269.35K	264.51K	20.84K	-129.21K	-798.46K	-859.47K	-422.29K	-134.38K	-242.72K	-158.25K	77.94K	-218.81K	-60.17K	-238.91K	-226.59K	-99.3K	n/a
Other Non-Cash Items	8.31M	8.35M	3.77M	804K	224K	247K	340K	339K	328K	317K	223K	182K	1.54M	1.84M	2.13M	2.17M	1.07M	914.74K	554.98K	-1.04M	-1.4M	-981.33K	-956.47K	590.05K	519.61K	55.45K	13.51K	61.7K	127.76K	-33.99K	46.05K	-6.66K	40.63K	54.2K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.56M	3.08M	6.66M	8.58M	10.44M	5.63M	5.55M	4.28M	-2.86M	-2.83M	-5.23M	-5.21M	-3.09M	-1.29M	-1.19M	-1.75M	43.51K	647.28K	820.62K	554.28K	-260.88K	-510.54K	-546.7K	-137.8K	379.67K	-192.83K	-124.45K	112.77K	-70.63K	-60.17K	-238.91K	-226.59K	-99.3K	n/a
Operating Cash Flow	-33.36M	-25.75M	-23.03M	-18.32M	-11.98M	-14.27M	-13.38M	-14.96M	-22.69M	-26.77M	-31.33M	-32.28M	-28.5M	-21.12M	-16.89M	-13M	-8.94M	-6.98M	-5.23M	-5.03M	-5.38M	-5.41M	-3.92M	-3.12M	-2.06M	-1.97M	-1.68M	-946.64K	-761.83K	-634.02K	-479.38K	-391.57K	-247.54K	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-15M	-15M	-15M	-15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	2.55M	2.55M	2.55M	2.55M	n/a	n/a	n/a	n/a	-15M	-15M	-30M	-30M	-15M	-15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-100K	-100K	-100K	-100K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	2.55M	n/a	n/a	n/a	-1.85M	699K	n/a	n/a	-15.7M	-15.7M	-30M	-30M	-23.89B	-23.89B	-23.87B	-23.87B	-12.2B	-12.2B	-12.2B	-12.2B	-899.1M	-899.1M	-899.1M	-899.1M	-100K	-100K	-100K	-100K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-10M	-10M	-7.5M	-5M	-2.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.01M	1.01M	1.01M	n/a	-1.01M	-1.01M	-1.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.92M	15.5M	13M	-2.5M	-2.5M	-2.5M	n/a	n/a	30K	80.28M	81.42M	96.37M	96.36M	23.91B	23.91B	23.9B	23.9B	12.2B	12.2B	12.2B	12.2B	899.1M	899.1M	899.1M	899.1M	n/a	30K	1.69M	2.06M	2.16M	2.13M	471K	100K	n/a
Financial Cash Flow	18.21M	17.79M	6.27M	-6.72M	-4.22M	-2.42M	-699K	-699K	30K	729K	53.67M	68.62M	96.36M	23.97B	23.94B	23.92B	23.9B	12.22B	12.2B	12.2B	12.21B	911.31M	911.31M	906.35M	900M	900K	930K	2.58M	2.06M	2.16M	2.13M	471K	100K	n/a
Net Cash Flow	-14.93M	-8.26M	-16.76M	-25M	-16.3M	-15.59M	-13.39M	-15.73M	-22.66M	-27.07M	21.69M	21.39M	52.84M	60.16M	34.7M	39.41M	14.97M	16.93M	-4.55M	-118.39K	6.81M	6.73M	8.26M	4.09M	-1.18M	-1.19M	-843.93K	1.58M	1.23M	1.55M	1.66M	77.64K	-153.78K	n/a
Free Cash Flow	-33.36M	-25.75M	-23.03M	-18.32M	-11.98M	-14.27M	-13.38M	-14.96M	-22.69M	-26.77M	-31.33M	-47.28M	-43.5M	-36.12M	-31.89M	-13M	-8.94M	-6.98M	-5.23M	-5.03M	-5.38M	-5.41M	-3.92M	-3.12M	-2.06M	-1.97M	-1.68M	-946.64K	-761.83K	-634.02K	-479.38K	-391.57K	-247.54K	n/a